nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—MPO—Carboplatin—ocular cancer	0.834	1	CbGbCtD
Tolmetin—TDO2—Monoamine Transport—RBL2—ocular cancer	0.0143	0.0866	CbGpPWpGaD
Tolmetin—CXCL8—Overview of nanoparticle effects—CCND3—ocular cancer	0.00674	0.0407	CbGpPWpGaD
Tolmetin—TDO2—Amino acid and derivative metabolism—PSPH—ocular cancer	0.00672	0.0406	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CRTC1—ocular cancer	0.00407	0.0246	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—CCND3—ocular cancer	0.00372	0.0225	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—ID2—ocular cancer	0.00326	0.0197	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—CCND3—ocular cancer	0.00295	0.0178	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN2C—ocular cancer	0.00294	0.0178	CbGpPWpGaD
Tolmetin—TDO2—Tryptophan metabolism—MDM2—ocular cancer	0.00272	0.0164	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—E2F1—ocular cancer	0.0024	0.0145	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—E2F5—ocular cancer	0.00223	0.0135	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CDK6—ocular cancer	0.00206	0.0125	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—CDK4—ocular cancer	0.00196	0.0118	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—GNA11—ocular cancer	0.00195	0.0118	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN2C—ocular cancer	0.00186	0.0112	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—GNAQ—ocular cancer	0.00181	0.011	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—H1F0—ocular cancer	0.00175	0.0106	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—RB1—ocular cancer	0.0017	0.0103	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—E2F1—ocular cancer	0.00164	0.0099	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—E2F2—ocular cancer	0.00149	0.00899	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—GNA11—ocular cancer	0.00146	0.00882	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—MDM2—ocular cancer	0.00145	0.00877	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2C—ocular cancer	0.00141	0.00849	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ocular cancer	0.00137	0.00826	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC1—ocular cancer	0.00137	0.00826	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—GNAQ—ocular cancer	0.00136	0.0082	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—HDAC1—ocular cancer	0.00134	0.0081	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—ocular cancer	0.00134	0.00807	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—H1F0—ocular cancer	0.00132	0.00799	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—E2F3—ocular cancer	0.00129	0.00779	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—RBBP4—ocular cancer	0.00129	0.00779	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDK6—ocular cancer	0.00128	0.00773	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—CCND1—ocular cancer	0.00127	0.00764	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PSPH—ocular cancer	0.00123	0.00746	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—CDKN1A—ocular cancer	0.00122	0.00739	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TFDP1—ocular cancer	0.0012	0.00724	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—CDK4—ocular cancer	0.00117	0.00707	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—E2F2—ocular cancer	0.00112	0.00679	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—ocular cancer	0.0011	0.00663	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—RB1—ocular cancer	0.00102	0.00615	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—MYC—ocular cancer	0.00101	0.00613	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—ocular cancer	0.00101	0.00611	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN2B—ocular cancer	0.000987	0.00596	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—E2F5—ocular cancer	0.000976	0.0059	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—E2F3—ocular cancer	0.000975	0.00589	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—RBBP4—ocular cancer	0.000975	0.00589	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TFDP1—ocular cancer	0.000906	0.00547	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—E2F1—ocular cancer	0.000906	0.00547	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—TGFB1—ocular cancer	0.000898	0.00542	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—TP53—ocular cancer	0.000833	0.00503	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—E2F1—ocular cancer	0.000825	0.00498	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDK6—ocular cancer	0.00081	0.00489	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CDKN1B—ocular cancer	0.000805	0.00487	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.000802	0.00484	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—HRAS—ocular cancer	0.000797	0.00481	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDK2—ocular cancer	0.000781	0.00472	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CCND1—ocular cancer	0.000768	0.00464	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.000768	0.00464	CbGpPWpGaD
Tolmetin—CXCL8—IL8- and CXCR1-mediated signaling events—AKT1—ocular cancer	0.000763	0.00461	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—CCND1—ocular cancer	0.000756	0.00457	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CDKN1A—ocular cancer	0.000743	0.00449	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDK4—ocular cancer	0.000738	0.00446	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—MYC—ocular cancer	0.000727	0.00439	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—E2F1—ocular cancer	0.000718	0.00434	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CDK2—ocular cancer	0.000711	0.0043	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—EP300—ocular cancer	0.000707	0.00427	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—HRAS—ocular cancer	0.000707	0.00427	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—TGFB1—ocular cancer	0.000702	0.00424	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—EP300—ocular cancer	0.000696	0.0042	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CDKN1B—ocular cancer	0.000691	0.00417	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CDK4—ocular cancer	0.000672	0.00406	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDK6—ocular cancer	0.00067	0.00405	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—MDM2—ocular cancer	0.000667	0.00403	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.000662	0.004	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CCND1—ocular cancer	0.000659	0.00398	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—EIF1AX—ocular cancer	0.000657	0.00397	CbGpPWpGaD
Tolmetin—CXCL8—IL8- and CXCR2-mediated signaling events—AKT1—ocular cancer	0.000654	0.00395	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.000651	0.00393	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—RB1—ocular cancer	0.000642	0.00388	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000638	0.00385	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN2B—ocular cancer	0.000624	0.00377	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—MYC—ocular cancer	0.000616	0.00372	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TP53—ocular cancer	0.000614	0.00371	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDK6—ocular cancer	0.000612	0.0037	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—EP300—ocular cancer	0.000607	0.00367	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.000593	0.00358	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—ocular cancer	0.000585	0.00354	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—RB1—ocular cancer	0.000585	0.00353	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—E2F1—ocular cancer	0.000573	0.00346	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.000562	0.00339	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—HRAS—ocular cancer	0.000553	0.00334	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—MDM2—ocular cancer	0.000547	0.00331	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.000545	0.00329	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.000544	0.00329	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.000535	0.00323	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—MYC—ocular cancer	0.000529	0.00319	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TGFB1—ocular cancer	0.000528	0.00319	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—RPL39—ocular cancer	0.000526	0.00317	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—AKT1—ocular cancer	0.000504	0.00305	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN1B—ocular cancer	0.0005	0.00302	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN1B—ocular cancer	0.0005	0.00302	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDK2—ocular cancer	0.000494	0.00299	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—AKT1—ocular cancer	0.000488	0.00295	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—HRAS—ocular cancer	0.000484	0.00292	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TGFB1—ocular cancer	0.000479	0.00289	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.000475	0.00287	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2B—ocular cancer	0.000472	0.00285	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDK4—ocular cancer	0.000467	0.00282	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN1A—ocular cancer	0.000461	0.00279	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN1A—ocular cancer	0.000461	0.00279	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CDKN1B—ocular cancer	0.000455	0.00275	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—HRAS—ocular cancer	0.000446	0.0027	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TP53—ocular cancer	0.000434	0.00262	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CCND1—ocular cancer	0.000434	0.00262	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—E2F1—ocular cancer	0.000433	0.00262	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—TGFB1—ocular cancer	0.000424	0.00256	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.000424	0.00256	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—RB1—ocular cancer	0.000406	0.00245	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—AKT1—ocular cancer	0.000394	0.00238	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.000391	0.00236	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GNA11—ocular cancer	0.000388	0.00235	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.000383	0.00231	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TGFB1—ocular cancer	0.000381	0.0023	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDK2—ocular cancer	0.000374	0.00226	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.000372	0.00225	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—E2F1—ocular cancer	0.000361	0.00218	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GNAQ—ocular cancer	0.000361	0.00218	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDK4—ocular cancer	0.000353	0.00213	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MYC—ocular cancer	0.000348	0.0021	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TGFB1—ocular cancer	0.000347	0.0021	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—MDM2—ocular cancer	0.000346	0.00209	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	0.000331	0.002	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000324	0.00196	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.000323	0.00195	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00032	0.00193	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN1B—ocular cancer	0.000316	0.00191	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—ocular cancer	0.000314	0.0019	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDK2—ocular cancer	0.000312	0.00188	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—RB1—ocular cancer	0.000307	0.00185	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—HRAS—ocular cancer	0.0003	0.00181	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—AKT1—ocular cancer	0.000295	0.00178	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDK4—ocular cancer	0.000295	0.00178	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN1A—ocular cancer	0.000292	0.00176	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—ocular cancer	0.000286	0.00173	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000271	0.00164	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000268	0.00162	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SAG—ocular cancer	0.000266	0.00161	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PSPH—ocular cancer	0.000265	0.0016	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MDM2—ocular cancer	0.000262	0.00158	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN1B—ocular cancer	0.000262	0.00158	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—RB1—ocular cancer	0.000256	0.00155	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000255	0.00154	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CCND1—ocular cancer	0.00025	0.00151	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000246	0.00148	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN1A—ocular cancer	0.000241	0.00146	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1B—ocular cancer	0.000239	0.00144	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—GNA11—ocular cancer	0.000236	0.00142	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—E2F5—ocular cancer	0.000236	0.00142	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—E2F4—ocular cancer	0.000231	0.0014	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—EP300—ocular cancer	0.00023	0.00139	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RBL1—ocular cancer	0.000226	0.00137	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1A—ocular cancer	0.000221	0.00133	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—GNAQ—ocular cancer	0.000219	0.00132	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GNA11—ocular cancer	0.000214	0.00129	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000212	0.00128	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000212	0.00128	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PSPH—ocular cancer	0.000211	0.00127	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—EP300—ocular cancer	0.00021	0.00127	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.0002	0.00121	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—ocular cancer	0.0002	0.00121	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDKN1B—ocular cancer	0.000199	0.0012	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GNAQ—ocular cancer	0.000199	0.0012	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—ocular cancer	0.000199	0.0012	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—E2F3—ocular cancer	0.000196	0.00119	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—ocular cancer	0.00019	0.00115	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TFDP1—ocular cancer	0.000183	0.0011	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SAG—ocular cancer	0.000167	0.00101	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HRAS—ocular cancer	0.000157	0.00095	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—ocular cancer	0.000153	0.000922	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TGFB1—ocular cancer	0.000152	0.000919	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—ocular cancer	0.00015	0.000907	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000149	0.000897	CbGpPWpGaD
Tolmetin—PTGS2—Disease—E2F5—ocular cancer	0.000147	0.000891	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAML2—ocular cancer	0.000145	0.000876	CbGpPWpGaD
Tolmetin—PTGS2—Disease—E2F4—ocular cancer	0.000144	0.000873	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPL39—ocular cancer	0.000142	0.000856	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RBL1—ocular cancer	0.000142	0.000856	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000136	0.000819	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—EP300—ocular cancer	0.00013	0.000784	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000129	0.000782	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GNA11—ocular cancer	0.000127	0.000764	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—ocular cancer	0.000125	0.000757	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000125	0.000756	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000119	0.000719	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GNAQ—ocular cancer	0.000118	0.000711	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TFDP1—ocular cancer	0.000114	0.00069	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HDAC1—ocular cancer	0.000106	0.000641	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000104	0.000627	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000104	0.000625	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN2B—ocular cancer	9.51e-05	0.000574	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAML2—ocular cancer	9.07e-05	0.000548	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—E2F1—ocular cancer	8.72e-05	0.000527	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	8.52e-05	0.000515	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GNA11—ocular cancer	8.35e-05	0.000504	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—ocular cancer	7.84e-05	0.000474	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GNAQ—ocular cancer	7.76e-05	0.000469	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	7.2e-05	0.000435	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HDAC1—ocular cancer	6.63e-05	0.000401	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GNA11—ocular cancer	6.63e-05	0.0004	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.26e-05	0.000378	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GNAQ—ocular cancer	6.16e-05	0.000372	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN2B—ocular cancer	5.95e-05	0.000359	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MDM2—ocular cancer	5.27e-05	0.000319	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.97e-05	0.0003	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—ocular cancer	4.9e-05	0.000296	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1B—ocular cancer	4.81e-05	0.000291	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—ocular cancer	4.76e-05	0.000288	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—ocular cancer	4.59e-05	0.000277	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1A—ocular cancer	4.44e-05	0.000268	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—ocular cancer	4.32e-05	0.000261	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EP300—ocular cancer	4.23e-05	0.000255	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—ocular cancer	3.68e-05	0.000223	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—ocular cancer	3.68e-05	0.000222	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MDM2—ocular cancer	3.3e-05	0.000199	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—ocular cancer	3.03e-05	0.000183	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1B—ocular cancer	3.01e-05	0.000182	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—ocular cancer	2.89e-05	0.000175	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—EP300—ocular cancer	2.79e-05	0.000169	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1A—ocular cancer	2.78e-05	0.000168	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EP300—ocular cancer	2.64e-05	0.00016	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—ocular cancer	2.55e-05	0.000154	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—ocular cancer	2.3e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—ocular cancer	2.3e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—EP300—ocular cancer	2.21e-05	0.000134	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—ocular cancer	1.81e-05	0.000109	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—ocular cancer	1.69e-05	0.000102	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—ocular cancer	1.6e-05	9.65e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—ocular cancer	1.34e-05	8.08e-05	CbGpPWpGaD
